文献速递甲状腺与颈部外科

甲状腺乳头状癌跳跃转移与侧颈淋巴结转移的危险因素

Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
PubMed 文献 · Surgery · 2019-03-12

该研究回顾性分析721例接受全甲状腺切除联合中央区及侧颈淋巴结清扫的甲状腺乳头状癌患者,跳跃转移率为7.4%(42/567)。多因素分析显示女性及微小癌(≤1 cm)是跳跃转移的独立危险因素,而肿瘤较大、中央区淋巴结转移及清扫数目增多是侧颈淋巴结转移的危险因素。

要点

  • 女性及微小癌(≤1 cm)是甲状腺乳头状癌跳跃转移的独立危险因素。
  • 肿瘤较大、中央区淋巴结转移及中央区/侧颈淋巴结清扫数目增多与侧颈淋巴结转移风险相关。
  • 完整彻底的中央区清扫可能减少跳跃转移的假阳性检出。

核心结论

  • 肿瘤较大、中央区淋巴结转移及中央区和侧颈淋巴结清扫数目增多是甲状腺乳头状癌侧颈淋巴结转移的预测因素。
  • 微小癌是跳跃转移的独立危险因素,完整彻底的中央区清扫可能减少跳跃转移的假阳性检出。

研究设计与样本

  • 回顾性队列研究,纳入2013至2018年接受全甲状腺切除联合中央区及侧颈淋巴结清扫的721例甲状腺乳头状癌患者,采用多因素logistic回归分析。

主要发现

  • 跳跃转移率为7.4%(42/567例)。
  • 女性(OR 2.29,95%CI 1.02-5.16)和微小癌(≤1 cm)(OR 2.84,95%CI 1.46-5.16)是跳跃转移的独立危险因素。
  • 甲状腺内播散(OR 0.13,95%CI 0.02-0.99)及中央区淋巴结清扫数目增多(OR 0.88,95%CI 0.83-0.94)与跳跃转移呈负相关。
  • 肿瘤较大(OR 1.67,95%CI 1.08-2.59)、中央区淋巴结转移(OR 3.07,95%CI 1.71-5.52)、中央区淋巴结清扫数目增多(OR 1.25,95%CI 1.14-1.37)及侧颈淋巴结清扫数目增多(OR 1.07,95%CI 1.04-1.10)与侧颈淋巴结转移风险相关。

临床怎么用

  • 对微小癌或女性患者应警惕跳跃转移可能,评估侧颈淋巴结状态。
  • 中央区淋巴结转移或肿瘤较大者侧颈淋巴结转移风险较高,需重视侧颈评估。
  • 行中央区淋巴结清扫时应力求完整彻底,以减少跳跃转移的假阳性判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lymph node metastases from papillary thyroid cancer is believed to disseminate sequentially, first to the central neck and later to the lateral neck. Skip metastases of papillary thyroid cancer, however, are defined as lateral lymph node metastasis without central lymph node metastasis. The aim of this study was to investigate the risk factors for skip metastases and lateral lymph node metastasis of papillary thyroid cancer. METHODS: We reviewed 721 papillary thyroid cancer patients undergoing total thyroidectomy with central lymph node dissection and lateral lymph node dissection during 2013 to 2018. Multivariate logistic regression analysis was performed to identify clinicopathologic risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer. RESULTS: The rate of skip metastases was 7.4% (42 of 567 patients). Multivariate analysis showed that female sex and papillary thyroid microcarcinoma (≤ 1 cm) were independent risk factors for skip metastases, with odds ratios ([OR], 95% confidence interval [CI]) of 2.29 (1.02-5.16) and 2.84 (1.46-5.16), respectively. Intrathyroidal spread of papillary thyroid cancer and an increased number of central lymph nodes dissected were inversely associated with skip metastases with ORs (95% CI) of 0.13 (0.02-0.99) and 0.88 (0.83-0.94), respectively. In contrast, a greater tumor size, central lymph node metastasis, an increased number of central lymph nodes dissected, and an increased number of lateral lymph nodes dissected were associated with a lateral lymph node metastasis risk of papillary thyroid cancer, with ORs (95% CI) as follow: 1.67 (1.08-2.59), 3.07 (1.71-5.52), 1.25 (1.14-1.37), and 1.07 (1.04-1.10), respectively, by multivariate analysis. CONCLUSION: Greater tumor size, central lymph node metastasis, and an increased number of both central lymph nodes and lateral lymph nodes dissected were predictors for lateral lymph node metastasis of papillary thyroid cancer. In addition, papillary thyroid microcarcinoma was an independent risk factor for skip metastases. A complete and comprehensive central compartment dissection may decrease the false-positive detection of skip metastases of papillary thyroid cancer.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Zhao H, Huang T, Li H, et al. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer. Surgery. 2019. PMID: 30876667. doi:10.1016/j.surg.2019.01.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。